• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酰胺与吡罗昔康的节拍式化疗可有效延缓软组织肉瘤切除不完全的犬类肿瘤复发。

Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.

作者信息

Elmslie R E, Glawe P, Dow S W

机构信息

Veterinary Cancer Specialists, Englewood, CO, USA.

出版信息

J Vet Intern Med. 2008 Nov-Dec;22(6):1373-9. doi: 10.1111/j.1939-1676.2008.0179.x. Epub 2008 Oct 3.

DOI:10.1111/j.1939-1676.2008.0179.x
PMID:18976288
Abstract

BACKGROUND

Continuous administration of low doses of cyclophosphamide and standard doses of cyclooxygenase-inhibiting drugs has been shown to suppress tumor angiogenesis, reverse immunosuppression, and deplete regulatory T cells in cancer models.

HYPOTHESIS

We hypothesized that continuous treatment with low-dose cyclophosphamide and full-dose piroxicam would delay tumor recurrence in dogs with soft tissue sarcomas (STS).

ANIMALS

Eighty-five dogs with incompletely resected STS, 30 treated dogs, and 55 contemporary control dogs.

METHODS

Treatment outcomes in 85 dogs with incompletely resected STS were evaluated in a retrospective study. Dogs in the treatment group received continuously administered low-dose cyclophosphamide (10 mg/m2) and standard dose piroxicam (0.3 mg/kg) therapy. Time to local tumor recurrence (disease-free interval; DFI) was compared between the 30 treated dogs and 55 untreated control dogs matched for age and tumor site and grade.

RESULTS

DFI was significantly (P < .0001) prolonged for STS of all sites (trunk and extremity) in treated dogs compared with untreated control dogs. The DFI also was significantly longer in treated dogs when tumor site (trunk and extremity) was compared. Twelve treated dogs (40%) experienced mild toxicity (grade 1 and 2) at some point during treatment and 1 dog developed grade 4 cystitis. Every other day dosing was tolerated better than daily dosing.

CONCLUSIONS

Metronomic therapy with cyclophosphamide and piroxicam was very effective in preventing tumor recurrence in dogs with incompletely resected STS. These findings suggest that further evaluation of this approach is warranted as adjuvant therapy in dogs with highly metastatic tumors such as osteosarcoma and melanoma.

摘要

背景

在癌症模型中,持续给予低剂量环磷酰胺和标准剂量的环氧化酶抑制药物已显示可抑制肿瘤血管生成、逆转免疫抑制并消耗调节性T细胞。

假设

我们假设持续用低剂量环磷酰胺和全剂量吡罗昔康治疗可延迟软组织肉瘤(STS)犬的肿瘤复发。

动物

85只STS切除不完全的犬、30只接受治疗的犬和55只同期对照犬。

方法

在一项回顾性研究中评估了85只STS切除不完全的犬的治疗结果。治疗组的犬接受持续给予的低剂量环磷酰胺(10mg/m²)和标准剂量吡罗昔康(0.3mg/kg)治疗。比较了30只接受治疗的犬和55只年龄、肿瘤部位和分级相匹配的未治疗对照犬的局部肿瘤复发时间(无病间隔期;DFI)。

结果

与未治疗的对照犬相比,治疗犬所有部位(躯干和四肢)的STS的DFI显著延长(P <.0001)。当比较肿瘤部位(躯干和四肢)时,治疗犬的DFI也显著更长。12只治疗犬(40%)在治疗期间的某个时间点出现轻度毒性(1级和2级),1只犬发生4级膀胱炎。隔日给药比每日给药耐受性更好。

结论

环磷酰胺和吡罗昔康的节拍式疗法在预防STS切除不完全的犬的肿瘤复发方面非常有效。这些发现表明,作为骨肉瘤和黑色素瘤等高转移性肿瘤犬的辅助治疗,有必要对这种方法进行进一步评估。

相似文献

1
Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas.环磷酰胺与吡罗昔康的节拍式化疗可有效延缓软组织肉瘤切除不完全的犬类肿瘤复发。
J Vet Intern Med. 2008 Nov-Dec;22(6):1373-9. doi: 10.1111/j.1939-1676.2008.0179.x. Epub 2008 Oct 3.
2
Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma.低剂量环磷酰胺选择性地减少调节性 T 细胞并抑制软组织肉瘤犬的血管生成。
J Vet Intern Med. 2011 Jul-Aug;25(4):920-6. doi: 10.1111/j.1939-1676.2011.0753.x. Epub 2011 Jul 7.
3
Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.骨肉瘤犬采用节拍化疗与最大耐受剂量化疗联合方案的毒性评估
J Small Anim Pract. 2014 Jul;55(7):369-74. doi: 10.1111/jsap.12228. Epub 2014 May 7.
4
Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.采用小剂量环磷酰胺、吡罗昔康和沙利度胺治疗晚期原发性肺癌犬的生存分析。
Vet Comp Oncol. 2018 Sep;16(3):399-408. doi: 10.1111/vco.12393. Epub 2018 Mar 6.
5
Soft-tissue sarcomas in dogs: a review.犬软组织肉瘤综述
J Am Anim Hosp Assoc. 2005 Jul-Aug;41(4):241-6. doi: 10.5326/0410241.
6
Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.托西拉尼/吡罗昔康/环磷酰胺维持治疗对截肢及卡铂化疗后犬附肢骨肉瘤预后的影响:一项多机构研究
PLoS One. 2015 Apr 29;10(4):e0124889. doi: 10.1371/journal.pone.0124889. eCollection 2015.
7
Long-term outcomes of dogs undergoing surgical resection of mast cell tumors and soft tissue sarcomas: A prospective 2-year-long study.接受肥大细胞瘤和软组织肉瘤手术切除的犬类的长期预后:一项为期2年的前瞻性研究。
Vet Surg. 2020 Jan;49(1):96-105. doi: 10.1111/vsu.13225. Epub 2019 May 2.
8
Single high-dose radiation therapy and liquid fiducial markers can be used in dogs with incompletely resected soft tissue sarcomas.对于未完全切除的软组织肉瘤的犬,可以采用单次大剂量放疗和液体基准标记物。
J Am Vet Med Assoc. 2023 Jul 12;261(10):1-8. doi: 10.2460/javma.23.02.0119. Print 2023 Oct 1.
9
Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).犬软组织肉瘤手术治疗的预后因素:75例病例(1986 - 1996年)
J Am Vet Med Assoc. 1997 Nov 1;211(9):1147-51.
10
Evaluation of local toxic effects and outcomes for dogs undergoing marginal tumor excision with intralesional cisplatin-impregnated bead placement for treatment of soft tissue sarcomas: 62 cases (2009-2012).对采用瘤内放置顺铂浸渍微球进行边缘性肿瘤切除治疗软组织肉瘤的犬只局部毒性作用和预后情况的评估:62例病例(2009 - 2012年)
J Am Vet Med Assoc. 2016 May 15;248(10):1148-56. doi: 10.2460/javma.248.10.1148.

引用本文的文献

1
Clinical, Histological, and Immunohistochemical Insights into a Canine Hepatic Myofibroblastic Sarcoma.犬肝肌成纤维细胞肉瘤的临床、组织学及免疫组化研究
Vet Sci. 2025 May 26;12(6):521. doi: 10.3390/vetsci12060521.
2
Evaluation of a Novel Cisplatin Poloxamer Gel Formulation in the Treatment of Incompletely Excised Soft-Tissue Sarcomas: 42 Dogs.新型顺铂泊洛沙姆凝胶制剂治疗软组织肉瘤切除不完全的犬:42只犬的研究
Vet Sci. 2025 Feb 27;12(3):202. doi: 10.3390/vetsci12030202.
3
Multimodal Blockade of the Renin-Angiotensin System in the Treatment of Cancer in Dogs Has Mild Adverse Effects in Some Dogs.
肾素-血管紧张素系统的多模式阻断在犬类癌症治疗中对部分犬有轻微不良反应。
Vet Sci. 2024 Jun 17;11(6):275. doi: 10.3390/vetsci11060275.
4
Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology.节拍化疗:犬猫肿瘤学中从理论到临床应用的桥梁
Front Vet Sci. 2024 Jun 6;11:1397376. doi: 10.3389/fvets.2024.1397376. eCollection 2024.
5
A retrospective study of chemotherapeutic effect without wide-margin surgery or radiation therapy in dogs with oral malignant melanoma.一项回顾性研究,探讨未行广泛手术切除和放疗的情况下,犬口腔恶性黑色素瘤的化疗效果。
Can Vet J. 2024 Apr;65(4):343-350.
6
Canine Mammary Tumors: Classification, Biomarkers, Traditional and Personalized Therapies.犬乳腺肿瘤:分类、生物标志物、传统疗法与个性化疗法
Int J Mol Sci. 2024 Mar 1;25(5):2891. doi: 10.3390/ijms25052891.
7
Review of local extravascular delivery systems for chemotherapeutic agents in small animals and horses.小动物和马中化疗药物局部血管外给药系统的评价。
Can Vet J. 2023 Oct;64(10):957-967.
8
Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships.自然发生的犬类肉瘤:通过跨学科研究合作弥合从小鼠模型到人类患者的差距。
Front Oncol. 2023 Mar 23;13:1130215. doi: 10.3389/fonc.2023.1130215. eCollection 2023.
9
Insight into the Prospects for Tumor Therapy Based on Photodynamic Immunotherapy.基于光动力免疫疗法的肿瘤治疗前景洞察。
Pharmaceuticals (Basel). 2022 Nov 4;15(11):1359. doi: 10.3390/ph15111359.
10
Metronomic Chemotherapy for Palliative Treatment of Malignant Oral Tumors in Dogs.节拍化疗用于犬恶性口腔肿瘤的姑息治疗
Front Vet Sci. 2022 Mar 31;9:856399. doi: 10.3389/fvets.2022.856399. eCollection 2022.